Three things to know:
1. OCV Partners led the equity financings, with continued participation from Ortho Vision and Secocha Ventures, both existing investors.
2. Ossio has raised a total of $35 million to date. The company will use the proceeds for U.S. commercialization of its OSSIOfiber Intelligent Bone Regeneration Technology and operational expansion.
3. The OSSIOfiber technology uses a proprietary bio-integrative material designed to provide stability and maintain the alignment of bone fractures, osteotomies, arthrodesis and bone grafts during the healing process without permanent hardware.
More articles on devices:
21 spine devices receive FDA 510(k) clearance in February
FDA recorded 1.1M medical device-related injuries in internal reporting system — 4 things to know
SpineGuard granted patent for spinal ultrasound mapping technology — 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
